BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Probiodrug AG Presents Development Overview Of PQ912, Probiodrug’s QC-Inhibitor For Alzheimer’s Disease 7/10/2014 6:20:59 AM
Probiodrug AG To Present At Annual Biotechnology Industry Organization (BIO) International Convention 6/19/2014 8:18:11 AM
Probiodrug AG To Present At 2014 Asia Biotech Invest Conference 6/2/2014 7:40:33 AM
Probiodrug AG To Present At Annual BioEquity Europe Conference 5/19/2014 6:45:14 AM
Probiodrug AG And VU University Medical Center In Amsterdam To Collaborate On The Development Of Alzheimer's Disease Biomarker Assays 1/10/2014 8:42:13 AM
Probiodrug AG Divests Its CDK9 Inhibitor Program To AstraZeneca PLC (AZN) For Undisclosed Price 1/3/2014 7:01:22 AM
Probiodrug AG Funds Brigham and Women's Hospital’s Research Into Antibody Targeting Pyroglutamated Abeta For Treatment Of Alzheimer’s Disease 12/23/2013 9:26:53 AM
Probiodrug AG Provides Update on Clinical Development of PQ912, Its Most Advanced QC-Inhibitor for Alzheimer's Disease 7/16/2013 10:05:35 AM
Probiodrug AG Provides Further Insights into Science and Development of Glutaminyl Cyclase Inhibitor Development at 2013 Alzheimer’s Association International Conference 7/8/2013 6:38:47 AM
Probiodrug AG Strengthens Management Team and Expands Global Reach with Appointments of Ronald Black and Inge Lues 1/23/2013 7:14:57 AM
123